Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Adicionar filtros








Intervalo de ano
1.
China Journal of Chinese Materia Medica ; (24): 5438-5449, 2023.
Artigo em Chinês | WPRIM | ID: wpr-1008741

RESUMO

Huangqi Guizhi Wuwu Decoction is a classic prescription in traditional Chinese medicine(TCM) and is known for its effects of tonifying Qi, warming the meridians, and promoting blood circulation to alleviate obstruction. It is primarily used to treat conditions characterized by Qi stagnation, Yang deficiency, and obstruction, and it exhibits pharmacological effects such as immune regulation, anti-inflammation, analgesia, protection of the cardiovascular and cerebrovascular systems, itch relief, reduction of frostbite symptoms, antioxidative stress, promotion of cell apoptosis, and kidney protection. In modern clinical practice, it is commonly used to treat acute myocardial infarction, sequelae of cerebral infarction, cervical spondylosis, frozen shoulder, lower limb arteriosclerosis, lower limb vascular disorders, peripheral neuropathy in diabetes, and lupus nephritis. Recent research has focused on the chemical components, pharmacological effects, and clinical applications of Huangqi Guizhi Wuwu Decoction. Based on the "five principles" of quality markers(Q-markers) in TCM, this study predicted and analyzed the Q-markers of Huangqi Guizhi Wuwu Decoction. It suggested that astragaloside Ⅳ, formononetin, kaempferol, quercetin, cinnamic acid, cinnamaldehyde, 6-gingerol, paeoniflorin, albiflorin, and gallic acid could serve as Q-markers for Huangqi Guizhi Wuwu Decoction. The findings of this study can provide references for quality control of Huangqi Guizhi Wuwu Decoction and the development of new Chinese medicinal formulations.


Assuntos
Medicamentos de Ervas Chinesas/uso terapêutico , Medicina Tradicional Chinesa , Astragalus propinquus , Congelamento das Extremidades/tratamento farmacológico
2.
Artigo em Inglês | IMSEAR | ID: sea-18336

RESUMO

The efficacy of pentoxifylline--a haemorrheologic agent along with aspirin--an analgesic agent was evaluated in the amelioration of the tissue damage due to experimentally induced frostbite in 5 groups (20 each) of rats with body weights ranging between 175 and 200 g. Frostbite was produced experimentally in the hind limbs by exposing the animals to -15 +/- 1 degrees C for 1 h using the harness technique, with simultaneous recording of rectal and environmental temperatures. The degree of tissue damage was assessed on the basis of tissue necrosis after 15 days. Administration of pentoxifylline (40 mg/kg bw) 30 min before and 30 min after the cold exposure followed by two doses of the same daily for the next 5 days along with aspirin (5 mg/kg bw) twice daily for the same duration only after cold exposure, resulted in significant improvement in the degree of tissue preservation. The findings of this preliminary study have brought to light the potential usefulness of these drugs in the treatment of frostbite. The combined pharmacological properties of these two drugs might have altered the haemorrheologic status of blood and produced the curative beneficial effect in improving tissue survival following experimentally induced frostbite in rats.


Assuntos
Animais , Aspirina/uso terapêutico , Temperatura Baixa , Quimioterapia Combinada , Feminino , Congelamento das Extremidades/tratamento farmacológico , Masculino , Necrose , Pentoxifilina/uso terapêutico , Inibidores da Agregação Plaquetária/uso terapêutico , Ratos , Ratos Sprague-Dawley , Vasodilatadores/uso terapêutico
3.
Rev. chil. cir ; 48(5): 513-5, oct. 1996.
Artigo em Espanhol | LILACS | ID: lil-194896

RESUMO

Desde 1979 a 1993, se han atendido 14 pacientes con congelamiento en las extremidades superiores e inferiores. Los 14 pacientes fueron de sexo masculino, con edades entre 19 y 28 años. Estos 14 pacientesaoprtaron un total de 78 dedos afectados, 50 dedos de los miembros superiores y 28 en los pies. Clínicamente la mayoría fueron congelamiento de 2º. El tratamiento médico comprendió reposo, uso de antiinflamatorios, antiagregantes plaquetarios y vasodilatadores en forma tardía. Las amputaciones de necesidad se efectuaron a los 24 días en los más precoces y a los 60 días en los más tardíos. En su mayoría fueron amputaciones parciales y en 2 casos se amputaron ortejos en forma total. Se realizaron algunos injertos demoepidérmicos y plastía de pulpejos


Assuntos
Humanos , Masculino , Adulto , Congelamento das Extremidades/terapia , Amputação Cirúrgica , Repouso em Cama , Evolução Clínica , Congelamento das Extremidades/cirurgia , Congelamento das Extremidades/tratamento farmacológico , Transplante de Tecidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA